A Reactive Antibody Platform for One-Step Production of Antibody–Drug Conjugates through a Diels–Alder Reaction with Maleimide

Author:

St. Amant Andre H.1ORCID,Huang Fengying2,Lin Jia2,Lemen Daniel2ORCID,Chakiath Chacko2,Mao Shenlan3,Fazenbaker Christine3,Zhong Haihong3,Harper Jay3,Xu Wenshu4,Patel Neki4,Adams Lauren4,Vijayakrishnan Balakumar4,Howard Philip W.4,Marelli Marcello3,Wu Herren2,Gao Changshou2,Read de Alaniz Javier1ORCID,Christie R. James2ORCID

Affiliation:

1. Department of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106-9510, United States

2. Antibody Discovery and Protein Engineering Department, AstraZeneca R&D, Gaithersburg, Maryland 20878, United States

3. AstraZeneca Oncology R&D, Gaithersburg, Maryland 20878, United States

4. Spirogen, London E1 2AX, United Kingdom

Funder

Natural Sciences and Engineering Research Council of Canada

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3